D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Donegal Group Class A
DGICA
$712M
| $704K | ﹤0.01% |
+45,478
| New | +$707K |
|
3277
PACS Group
PACS
$7.42B
| $702K | ﹤0.01% |
+53,585
| New | +$1.37M |
|
3278
Commercial Metals
CMC
$7.82B
| $702K | ﹤0.01% |
14,157
-63,839
| -82% | -$3.6M |
|
3279
Agilon Health
AGL
$1.63B
| $702K | ﹤0.01% |
14,771
+80
| +0.5% | +$4.84K |
|
|
BLD
3280
DELISTED
TopBuild
BLD
| $698K | ﹤0.01% |
2,243
+1,109
| +98% | +$407K |
|
3281
Backblaze
BLZE
$705M
| $698K | ﹤0.01% |
115,994
+87,194
| +303% | +$592K |
|
3282
Alector
ALEC
$168M
| $697K | ﹤0.01% |
368,977
+177,985
| +93% | +$670K |
|
3283
iShares MSCI Europe Financials ETF
EUFN
$4.06B
| $693K | ﹤0.01% |
+29,737
| New | +$712K |
|
3284
CALL
Evolent Health
EVH
$407M
| $692K | ﹤0.01% |
61,500
| – | – |
|
|
CCRD
3285
DELISTED
CoreCard
CCRD
| $691K | ﹤0.01% |
30,450
+19,168
| +170% | +$339K |
|
3286
PUT
Insmed
INSM
$22.8B
| $690K | ﹤0.01% |
10,000
| – | – |
|
3287
PUT
Sphere Entertainment
SPHR
$4.89B
| $689K | ﹤0.01% |
17,100
+6,100
| +55% | +$255K |
|
3288
CALL
Ascendis Pharma A/S
ASND
$16.3B
| $688K | ﹤0.01% |
5,000
| – | – |
|
3289
Ranger Energy Services
RNGR
$355M
| $687K | ﹤0.01% |
+44,394
| New | +$637K |
|
3290
PUT
Comstock Resources
CRK
$3.64B
| $687K | ﹤0.01% |
37,700
| – | – |
|
3291
Avantis US Small Cap Equity ETF
AVSC
$3.09B
| $684K | ﹤0.01% |
12,583
-610
| -5% | -$34.1K |
|
|
BNY
3292
CALL
Bank of New York Mellon
BNY
$106B
| $684K | ﹤0.01% |
+8,900
| New | +$688K |
|
3293
Luxfer Holdings
LXFR
$458M
| $683K | ﹤0.01% |
52,173
-33,726
| -39% | -$461K |
|
3294
PUT
Albertsons Companies
ACI
$5.68B
| $680K | ﹤0.01% |
+34,600
| New | +$656K |
|
3295
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
| $679K | ﹤0.01% |
+10,393
| New | +$722K |
|
3296
Puma Biotechnology
PBYI
$404M
| $679K | ﹤0.01% |
222,608
+165,220
| +288% | +$481K |
|
3297
PUT
Cintas
CTAS
$86.2B
| $676K | ﹤0.01% |
+3,700
| New | +$778K |
|
3298
CALL
Ero Copper
ERO
$2.67B
| $674K | ﹤0.01% |
50,000
| – | – |
|
3299
MGIC Investment
MTG
$6.44B
| $673K | ﹤0.01% |
28,399
-72,572
| -72% | -$1.81M |
|
3300
Inogen
INGN
$174M
| $672K | ﹤0.01% |
73,282
-77,489
| -51% | -$725K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.